Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

NCT02104830 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia

Interventions

BIOLOGICAL: Empegfilrastim 6 mg
BIOLOGICAL: Filgrastim
BIOLOGICAL: Placebo №1
BIOLOGICAL: Placebo №2
BIOLOGICAL: Empegfilrastim 7.5 mg

Sponsor

Biocad